PFE
Stock Details
PFE is Pfizer Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 42.02$. Average daily volumn in 3 months 23.08M. Market cap 230.29B
Stock symbol : PFE. Exchange : NYSE. Currency : USD Lastest price : 40.80$. Total volume : 23.26M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
Pfizer Inc. (PFE)
Last Price
40.80$Change
0.42Volume
23.26M
| Previous Close | 40.38 |
| Open | 40.55 |
| Day Range | 40.28-40.83 |
| Bid | 40.78 x 4k |
| Ask | 40.79 x 2.9k |
| Volume | 23.26M |
| Average Volume | 23.08M |
| Market Cap | 230.29B |
| Beta | 0.59 |
| 52 Week Range | 39.23-56.32 |
| Trailing P/E | 7.38 |
| Foward P/E | 10.82 |
| Dividend (Yield %) | 4.06% |
| Ex-Dividend Date | 2023-01-26 |
Financial Details
Organization
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRN... A and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Market Cap:
230.29BRevenue:
100.33BTotal Assets:
197.21BTotal Cash:
416M
News about "Pfizer Inc."
Pfizer Inc. (PFE) Sitting On The Launchpad, Waiting For The Long Term Buyers
Source from : stocksregister - 10 hours ago
Pfizer Inc. (NYSE:PFE) concluded the trading at $40.80 on Friday, March 31 with a rise of 1.04% from its closing price on previous day. Taking a look at stock we notice that its last check on previous ...See details»
Pfizer Inc. stock outperforms competitors despite losses on the day
Source from : MarketWatch - 4 days ago
Shares of Pfizer Inc. sank 0.57% to $39.99 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 ...See details»
Pfizer Inc
Source from : Reuters - 2 days ago
2023 Healthcare & Pharmaceuticalscategory FDA advisers back Pfizer's COVID treatment for full approval, article with image March 16, 2023 Businesscategory U.S. FDA advisers vote in favor of full ...See details»
Pfizer Inc. (PFE) Shares Down Despite Recent Market Volatility
Source from : newsheater - 12 days ago
Pfizer Inc. (NYSE: PFE)’s stock price has decreased by -0.67 compared to its previous closing price of 40.37. Nevertheless, the company has seen a 1.80% surge in its stock price over the last five ...See details»
PAC Profile: Pfizer Inc
Source from : OpenSecrets.org - 6 days ago
*Based on data released by the Federal Election Commission on March 26, 2023 except for independent expenditure and communication cost, contributions to federal candidates, and contributions from ...See details»
Pfizer Invests $43 Billion to Battle Cancer
Source from : Stockhouse - 19 days ago
Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global biotechnology company ...See details»
Pfizer And Astellas Say Phase 3 EMBARK Study Of XTANDI To Treat Prostate Cancer Meets Primary Goal
Source from : Business Insider - 9 days ago
Thursday said Phase 3 EMBARK study of XTANDI for the treatment of prostate cancer met its primary goal. EMBARK study enrolled 1,068 patients with non-metastatic castration-sensitive prostate cancer ...See details»
Pfizer to replace migraine drug packaging over child safety concerns
Source from : Yahoo News - 16 days ago
(Reuters) -Pfizer Inc said on Thursday it was working on a new child-proof packaging for its migraine drug, Nurtec ODT, after safety concerns led to a recall alert from the U.S. Consumer Product ...See details»
Pfizer's Latest Acquisition Strengthens The Case For PFE Stock
Source from : Mena FN - 15 days ago
5 stocks we like better than pfizer On March 13, 2023, pfizer, inc. (nyse:pfe) announced it was merging with seagen inc. (nasdaq:sgen) . Under terms of the definitive agreement, Pfizer will buy ...See details»
pfizer inc.
Source from : Fox Business - 12 days ago
Pfizer Inc and BioNTech's COVID vaccine was approved for use in children under 5 years old in June, and new studies have shown the vaccine to be 73.2% effective within that age group. Pfizer Inc ...See details»
Bear of the Day: Pfizer Inc. (PFE)
Source from : Yahoo News - 5 days ago
One stock residing in the realm, Pfizer PFE, has seen its near-term outlook shift negative over the last several months, pushing the stock down into a Zacks Rank #5 (Strong Sell). Image Source: Zacks ...See details»
PAC Profile: Pfizer Inc
Source from : OpenSecrets.org - 1 year ago
*Based on data released by the Federal Election Commission on February 26, 2023 except for independent expenditure and communication cost, contributions to federal candidates, and contributions from ...See details»
Pfizer Inc.
Source from : Wall Street Journal - 2 years ago
1 Day PFE 0.32% DJIA 0.43% S&P 500 0.57% Health Care/Life Sciences 0.09% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price ...See details»
Pfizer Inc.
Source from : Fortune - 3 years ago
© 2023 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...See details»